Revenio Group Oyj (LON:0KFH)
London · Delayed Price · Currency is GBP · Price in EUR 23.54
+0.19 (0.80%)
At close: Sep 5, 2025
Revenio Group Oyj Market Cap
Revenio Group Oyj has a market cap or net worth of 547.07 million as of September 18, 2025. Its market cap has decreased by -26.69% in one year.
Market Cap
547.07M
Enterprise Value
547.07M
Revenue
91.91M
Ranking
n/a
PE Ratio
35.27
Stock Price
23.54
Market Cap Chart
Since October 1, 2001, Revenio Group Oyj's market cap has increased from 8.52M to 547.07M, an increase of 6,322.62%. That is a compound annual growth rate of 18.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2025 | 547.07M | -6.66% |
| Dec 30, 2024 | 586.14M | -6.48% |
| Dec 29, 2023 | 626.76M | -31.13% |
| Dec 30, 2022 | 910.05M | -26.48% |
| Dec 30, 2021 | 1.24B | 2.64% |
| Dec 30, 2020 | 1.21B | 103.09% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 176.72B |
| GSK plc | 59.31B |
| Haleon | 30.58B |
| Smith & Nephew | 11.87B |
| ConvaTec Group | 4.76B |
| Hikma Pharmaceuticals | 3.60B |
| HUTCHMED (China) | 2.18B |
| Genus | 1.66B |